A Conversation with Geisinger Health System's David Ledbetter at ACMG
May 25, 2012
BioArray News editor Justin Petrone caught up with David Ledbetter, CSO of Geisinger Health System, at the recent Annual Clinical Genetics Meeting held in Charlotte, NC, to discuss the future of CMA as a first-tier test, classifying findings of uncertain significance, and more.
Other Genomeweb Videos



























